Polynucleotides HPT for Asian Skin Regeneration and Rejuvenation

• Published in: Clinical, cosmetic and investigational dermatology Vol. 17; pp. 417 - 431
• Main Authors: Lim, Ting Song, Liew, ShaoRong, Tee, Xiang Jie, Chong, Ian, Lo, Fui Jun, Ho, Meng Jun, Ong, KuokTjun, Cavallini, Maurizio
• Format: Journal Article
• Language: English
• Published: New Zealand Dove Medical Press Limited 01.01.2024; Dove Medical Press
• Subjects: Analysis; Care and treatment; Collagen; emergent perceptual skin quality categories; epcs; gais; global aesthetic improvement scale; Medical equipment; Nucleic acids; Physiological apparatus; pn hpt; polynucleotides hpt; quantificare; Skin; skin quality; Malaysia; emergent perceptual skin quality categories; PN HPT; GAIS; polynucleotides HPT; global aesthetic improvement scale; QuantifiCare; EPCs; skin quality
• ISSN: 1178-7015; 1178-7015
• DOI: 10.2147/CCID.S437942

Even lightly compromised skin may impact self-esteem and social behaviour. After intradermal infiltration, natural-origin Polynucleotides High Purification Technology (PN HPT) promote new collagen and extracellular matrix production, translating into a physiological correction of the ageing skin. The study aimed to explore the benefits of intradermal PN HPT on the four perceptual skin quality categories "Skin Tone Evenness", "Skin Surface Evenness", "Skin Firmness", and "Skin Glow" in a representative sample of 30 Asian subjects (mean age 40.2± 11.4 years old). Study protocol: three intradermal injections of a PN HPT-based Class III CE-marked medical device at T0 (baseline assessment and first treatment session), T1 (four weeks after baseline), and T2 (eight weeks after baseline), with efficacy and safety evaluations at T1, T2, T3 (four months after baseline) and T4 (six months after baseline). Quantitative and qualitative assessments: 3D skin analysis system QuantifiCare and Global Aesthetic Improvement Scale (GAIS, Investigator and Patient subscales). PN HPT treatment led to a meaningful and statistically significant improvement of the skin surface, firmness, pigmentation, and radiance, with no early- or late-onset adverse events and benefits persisting up to the sixth-month visit in all subjects. At T4, 33% and 43% of treated subjects felt "Much Improved" and "Very Much Improved" (optimal result); 56% and 44% of treated subjects felt "Satisfied" or "Very Satisfied". At T4, the mean Investigator GAIS scores were 3.33 out of 5.0 for the "Skin Tone Evenness" skin quality perceptual category, 3.46 for the "Skin Surface Evenness" category, 3.61 for "Skin Firmness", and 3.45 per for the radiance determinant of the "Skin Glow" category. Intradermal treatment with the PN HPT-based medical device led to a meaningful improvement of the skin surface, firmness, pigmentation, and radiance with complete safety. The aesthetic benefits persisted up to the sixth-month visit in all subjects.